Photo from academic.microsoft.com
Vinflunine (VFL) has been approved in Europe for second-line treatment of metastatic and advanced urothelial cancer after failure of platin-containing therapy. Since approval, the drug has been investigated in few… Click to show full abstract
Vinflunine (VFL) has been approved in Europe for second-line treatment of metastatic and advanced urothelial cancer after failure of platin-containing therapy. Since approval, the drug has been investigated in few clinical trials. Most of the currently available reports describe experiences with VFL in a daily clinical setting. This review gives a short overview on clinical experiences and clinical trials involving VFL since the approval of this drug in 2009.
Keywords:
treatment advanced;
urothelial cancer;
advanced urothelial;
vinflunine treatment
Journal Title: Therapeutic Advances in Urology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Therapeutic Advances in Urology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!